NCT00242593View on ClinicalTrials.gov

Rosiglitazone Effects on Cognition for Adults in Later Life

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Mild Cognitive Impairment
Interventions
DRUG

Rosiglitazone

4 mg twice daily oral rosiglitazone or placebo pill for 18 months

Trial Locations (3)

85006

Banner Alzheimer Institute, Phoenix

90095

UCLA Alzheimer's Disease Center, Los Angeles

98108

University of Washington/VA Puget Sound Health Care System, Seattle/Tacoma

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Washington

OTHER

NCT00242593 - Rosiglitazone Effects on Cognition for Adults in Later Life | Biotech Hunter | Biotech Hunter